However, a further characterization of Tregs based on the expression of regulatory, effector and activation molecules, including PD-1 expression, revealed no difference in terms of PD-1+ Treg cells as well as Treg/Teff ratio between SLE patients and healthy controls. The gene discussed is PDCD1; the disease is systemic lupus erythematosus.